Angola is set to create a pharmaceutical production complex by 2026, located in the Special Economic Zone in Icolo and Bengo. The facility will produce 1.7 million tablets and capsules annually, along with various injectable medicines and medical gases. Managed by Vitaflor and funded by the Angolan Sovereign Fund, initial construction has begun, with completion expected in 18 months.
Angola plans to establish a pharmaceutical production complex by 2026, strategically situated within the Special Economic Zone (ZEE) of Icolo and Bengo. This facility is anticipated to have the capability to produce 1.7 million tablets and capsules each year, alongside 50 million vials of injectable medications.
The undertaking, managed by Vitaflor, will also focus on manufacturing 35 million bags of serum and generating 13,000 kilograms of medical gases daily, as reported by Jornal de Angola. Currently in its preliminary phase, the project, funded by the Angolan Sovereign Fund (FSA), recently held a ceremony for the laying of the first stone, with expectations for completion within the next 18 months.
The Special Economic Zone is already host to more than 60 business initiatives, primarily in the food and pharmaceutical industries. Manuel Pedro, the president of the board of directors of the SEZ, indicated that in the forthcoming months, the nation will welcome several new industries to complement the existing 89 present in the area, which span various sectors.
In summary, Angola’s initiative to establish a pharmaceutical production complex reflects its commitment to enhancing healthcare capabilities. With significant production targets and support from the Angolan Sovereign Fund, this project promises to bolster the nation’s pharmaceutical landscape significantly. As it progresses, the SEZ could emerge as a central hub for industrial development in Angola.
Original Source: www.plenglish.com
